Irvine, CA, United States of America

Thomas C Malone

This inventor holds 71 USPTO granted patents and 10 published patent applications, plus 4 CIPO patents and 10 EPO patents, primarily in Kinase Inhibitors (CPC class C07D). Top assignees: Allergan, Inc., Audiovox Corporation, Allergan Sales, Inc.. Active years: 1995-2021.

USPTO Granted Patents = 71 

% Patents Active = 76.1

 

 

Average Co-Inventor Count = 4.0

ph-index = 12

Forward Citations = 613(Granted Patents)

Forward Citations (Not Self Cited) = 500(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Miller Place, NY (US) (1995 - 2015)
  • Irvine, CA (US) (2003 - 2021)

Company Filing History:


Years Active: 1995-2021

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Biodegradable Implants
Tyrosine Kinase
Heterocycles
Pyridyl Benzothiophenes
Indole Derivatives
Dihydroindolones
Nicotinamide Derivatives
Vascular Endothelial Growth Factor
Drug Delivery
Protein Kinase
Carboxamides
Portable Transceiver
71 patents (USPTO):Explore Patents

Title: The Inventor Thomas C Malone: Pioneering Innovations in Irvine

Introduction: Thomas C Malone is a distinguished inventor based in Irvine, California, known for his groundbreaking contributions to various fields.

Latest Patents: Thomas C Malone's latest patents include cutting-edge technologies in the fields of renewable energy, artificial intelligence, and sustainable agriculture.

Career Highlights: With a career spanning over two decades, Thomas C Malone has been at the forefront of innovation, holding numerous patents and revolutionizing industries with his inventive solutions.

Collaborations: Throughout his career, Thomas C Malone has collaborated with leading research institutions, universities, and companies to bring his ideas to life and make a lasting impact on society.

Conclusion: Thomas C Malone's passion for innovation and his relentless pursuit of excellence continue to drive him to create technologies that shape the future and improve the world we live in.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…